Ignite Creation Date:
2024-05-05 @ 11:36 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00085696
Status:
COMPLETED
Last Update Posted:
2008-02-11
First Post:
2004-06-11
Brief Title:
VELCADE Bortezomib With Rituximab in Subjects With Relapsed or Refractory Indolent B-Cell Lymphoma
Sponsor:
Millennium Pharmaceuticals Inc
Organization:
Millennium Pharmaceuticals Inc
Organization Data
Organization:
Millennium Pharmaceuticals Inc
Class:
INDUSTRY
Study ID:
M34103-061
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Millennium Pharmaceuticals Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None